alizarin has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dong, Q; Gong, W; Hou, Y; Jiao, X; Liang, H; Liu, M; Mu, J; Qian, C; Su, L; Xu, Z; Zhang, F; Zhu, X; Zhu, Y; Zou, C | 1 |
1 other study(ies) available for alizarin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.
Topics: Anthraquinones; Apoptosis; Cell Line, Tumor; Humans; NF-kappa B; Pancreatic Neoplasms; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2022 |